Physician

John Ponugupati, M.D.

According to 2025 Medicare claims, John Ponugupati, M.D. (NPI: 1124274303) practices hematology/oncology in the Charleston, WV market, with the plurality of this provider's patient population coming from Kanawha, WV. This provider's primary affiliated billing organization is THS PHYSICIAN PARTNERS INC (NPI: 1871866806; TIN: 45-4395947) and primary practice location at 25309-1474. Ponugupati is affiliated with the ACO West Virginia (ACO ID: A3563), Vandalia Health Network (ACO ID: A4513), and Aledade 101 Regional MSSP (ACO ID: A5216), participating under the MSSP model.

Ponugupati's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 422 traditional Medicare patients, billed 1,647 HCPCS/CPT codes, and received $109,281 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 1,381 prescription claims across 217 beneficiaries totaling $4,359,768 in drug costs, led by Ibrance (Palbociclib). DME data shows 99 claims. Open Payments data shows 4 records totaling $472. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $23,539 to $109,281. Similarly, Part D prescription costs have moved sharply higher in recent years, from $166,171 to $4,359,768. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,228 and ending at $5,466.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	115	355	$23,539
2016	173	666	$36,381
2017	193	695	$37,912
2018	254	803	$44,061
2019	339	1,394	$82,097
2020	307	1,330	$75,062
2021	291	892	$60,066
2022	369	1,434	$90,169
2023	426	2,005	$135,198
2024	422	1,647	$109,281

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	44	203	$166,171
2016	75	359	$276,279
2017	72	493	$267,199
2018	93	488	$404,168
2019	128	847	$747,331
2020	116	834	$1,317,794
2021	126	802	$1,282,924
2022	183	1,199	$2,626,057
2023	209	1,332	$3,608,872
2024	217	1,381	$4,359,768

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	39	$911
2016	N/R	N/R	N/R
2017	N/R	138	$5,668
2018	N/R	N/R	N/R
2019	N/R	44	$1,971
2020	N/R	80	$7,799
2021	N/R	80	$7,215
2022	N/R	90	$8,074
2023	N/R	156	$4,481
2024	N/R	99	$6,505

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	88	100	$96
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	52	52	$86
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	296	687	$65
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	139	586	$59
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	70	86	$44

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	41	1,134	$616,875
Lenvima	Lenvatinib Mesylate	16	480	$372,243
Calquence	Acalabrutinib Maleate	20	600	$301,580
Promacta	Eltrombopag Olamine	40	1,200	$283,271
Retevmo	Selpercatinib	13	390	$274,154

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0781	Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient	Y	N/R	19	$3,611
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	40	$1,855
J9190	Injection, fluorouracil, 500 mg	N	N/R	40	$1,039

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$472	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John Ponugupati, M.D.?

Tedicare shows public-source Medicare data for John Ponugupati, M.D. (NPI 1124274303), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Ponugupati, M.D. have ACO affiliation data?

John Ponugupati, M.D. is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563), Vandalia Health Network (MSSP, ACO ID A4513), and Aledade 101 Regional MSSP (MSSP, ACO ID A5216).

What billing organization is linked to John Ponugupati, M.D.?

John Ponugupati, M.D. is linked to THS PHYSICIAN PARTNERS INC (billing NPI 1871866806) in the available physician profile data.

Does John Ponugupati, M.D. have Open Payments data?

John Ponugupati, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.